Live Update 
From the Liveblog of
Tuesday, April 21, 2015
From the Liveblog of
Tuesday, April 21, 2015
Teva offers to buy Mylan in $400-billion deal
Add ToI as a Preferred Source on GoogleIsraeli pharmaceutical giant Teva is offering to buy Mylan in a cash-and-stock deal valued at about $40.1 billion.
The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.
Teva Pharmaceutical Industries Ltd. offered to pay $82 per share, a 21-percent premium to Mylan’s closing price on Monday.
Mylan last week expressed doubts that regulators would approve a deal between Teva and Mylan.
— AP
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here